VMD VIEMED HEALTHCARE INC revenue, earnings and financials

For the quarter ended June 30, 2026, VIEMED HEALTHCARE INC reported revenue of $78.1M (up 23.9% from a year earlier), net income of $2.76M and diluted EPS of $0.07; over the last four quarters revenue was $302M and net income $15.0M; for the fiscal year ended December 2025 revenue was $270M, up 20.5% on the year before.

VMD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $270M, gross profit $155M, operating income $22.9M, net income $15.4M (margin 5.7%), EPS $0.37
• Fiscal year ended Dec 2024: revenue $224M, gross profit $133M, operating income $17.9M, net income $11.4M (margin 5.1%), EPS $0.28
• Fiscal year ended Dec 2023: revenue $183M, gross profit $113M, operating income $14.3M, net income $10.2M (margin 5.6%), EPS $0.25
• Fiscal year ended Dec 2022: revenue $139M, gross profit $84.7M, operating income $8.25M, net income $6.20M (margin 4.5%), EPS $0.16
• Fiscal year ended Dec 2021: revenue $117M, gross profit $73.4M, operating income $11.6M, net income $9.13M (margin 7.8%), EPS $0.22

VMD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $78.1M (up 23.9% year over year), net income $2.76M, EPS $0.07
• Quarter ended Mar 31, 2026: revenue $75.4M (up 27.5% year over year), net income $2.58M, EPS $0.06
• Quarter ended Dec 31, 2025 (from the annual report): revenue $76.2M (up 25.5% year over year), net income $6.11M, EPS $0.14
• Quarter ended Sep 30, 2025: revenue $71.9M (up 24.0% year over year), net income $3.51M, EPS $0.09
• Quarter ended Jun 30, 2025: revenue $63.1M (up 14.7% year over year), net income $3.16M, EPS $0.08
• Quarter ended Mar 31, 2025: revenue $59.1M (up 16.9% year over year), net income $2.63M, EPS $0.06
• Quarter ended Dec 31, 2024 (from the annual report): revenue $60.7M (up 19.6% year over year), net income $4.45M, EPS $0.10
• Quarter ended Sep 30, 2024: revenue $58.0M (up 17.4% year over year), net income $3.88M, EPS $0.10
• Quarter ended Jun 30, 2024: revenue $55.0M (up 26.9% year over year), net income $1.47M, EPS $0.04
• Quarter ended Mar 31, 2024: revenue $50.6M (up 27.9% year over year), net income $1.60M, EPS $0.04
• Quarter ended Dec 31, 2023 (from the annual report): revenue $50.7M (up 35.3% year over year), net income $3.43M, EPS $0.08
• Quarter ended Sep 30, 2023: revenue $49.4M (up 38.2% year over year), net income $2.92M, EPS $0.07
• Quarter ended Jun 30, 2023: revenue $43.3M (up 30.0% year over year), net income $2.33M, EPS $0.06
• Quarter ended Mar 31, 2023: revenue $39.6M (up 22.6% year over year), net income $1.52M, EPS $0.04
• Quarter ended Dec 31, 2022 (from the annual report): revenue $37.5M (up 17.4% year over year), net income $2.42M, EPS $0.07
• Quarter ended Sep 30, 2022: revenue $35.8M (up 22.1% year over year), net income $1.06M, EPS $0.03
• Quarter ended Jun 30, 2022: revenue $33.3M (up 21.6% year over year), net income $967K, EPS $0.02
• Quarter ended Mar 31, 2022: revenue $32.3M (up 13.5% year over year), net income $1.76M, EPS $0.04
• Quarter ended Dec 31, 2021 (from the annual report): revenue $32.0M, net income $4.09M, EPS $0.10
• Quarter ended Sep 30, 2021: revenue $29.3M, net income $1.79M, EPS $0.04

VMD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $51.9M, share buybacks $13.2M
• Fiscal year ended Dec 2024: operating cash flow $39.1M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow $45.2M, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow $27.7M, share buybacks $9.57M
• Fiscal year ended Dec 2021: operating cash flow $22.5M, share buybacks $0

VMD balance sheet

• Jun 30, 2026: cash $10.7M, total assets $204M, total liabilities $58.3M, shareholders' equity $144M, long-term debt $6.37M
• Mar 31, 2026: cash $9.76M, total assets $197M, total liabilities $51.6M, shareholders' equity $144M, long-term debt $8.33M
• Dec 31, 2025: cash $13.5M, total assets $199M, total liabilities $55.6M, shareholders' equity $142M, long-term debt $11.3M
• Sep 30, 2025: cash $11.1M, total assets $202M, total liabilities $66.9M, shareholders' equity $134M, long-term debt $19.6M
• Jun 30, 2025: cash $20.0M, total assets $185M, total liabilities $43.0M, shareholders' equity $140M, long-term debt $3.47M
• Mar 31, 2025: cash $10.2M, total assets $178M, total liabilities $41.3M, shareholders' equity $135M, long-term debt $3.53M
• Dec 31, 2024: cash $17.5M, total assets $177M, total liabilities $43.8M, shareholders' equity $131M, long-term debt $3.59M
• Sep 30, 2024: cash $11.3M, total assets $170M, total liabilities $42.7M, shareholders' equity $125M, long-term debt $3.65M

What is VMD's revenue?

VIEMED HEALTHCARE INC reported $302M of revenue over its last four quarters, through June 30, 2026.

Is VMD profitable?

Yes. VIEMED HEALTHCARE INC earned $15.0M over the last four quarters.

What is VMD's EPS?

Diluted earnings per share over the last four quarters were $0.36; $0.07 in the latest quarter.

VMD ownership and insider trades · All stocks